Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multidisciplinary behavioral therapy reduces rumination.
Nyyssönen M, Vilpponen O, Ståhl-Railila M, Liesto S, Mustonen T, Pikkarainen S, Arkkila P, Roine R, Sintonen H, Punkkinen J. Nyyssönen M, et al. Among authors: arkkila p. Neurogastroenterol Motil. 2024 Dec;36(12):e14919. doi: 10.1111/nmo.14919. Epub 2024 Sep 20. Neurogastroenterol Motil. 2024. PMID: 39301588
Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients.
Hartikainen AK, Jalanka J, Lahtinen P, Ponsero AJ, Mertsalmi T, Finnegan L, Crispie F, Cotter PD, Arkkila P, Satokari R. Hartikainen AK, et al. Among authors: arkkila p. NPJ Biofilms Microbiomes. 2024 Aug 28;10(1):73. doi: 10.1038/s41522-024-00549-x. NPJ Biofilms Microbiomes. 2024. PMID: 39191760 Free PMC article. Clinical Trial.
Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial.
Scheperjans F, Levo R, Bosch B, Lääperi M, Pereira PAB, Smolander OP, Aho VTE, Vetkas N, Toivio L, Kainulainen V, Fedorova TD, Lahtinen P, Ortiz R, Kaasinen V, Satokari R, Arkkila P. Scheperjans F, et al. Among authors: arkkila p. JAMA Neurol. 2024 Sep 1;81(9):925-938. doi: 10.1001/jamaneurol.2024.2305. JAMA Neurol. 2024. PMID: 39073834 Clinical Trial.
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials.
Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola, Jahnsen J, Louis E, Lukáš M, Reinisch W, Roblin X, Smith PJ, Kwon T, Kim J, Yoon S, Kim DH, Atreya R. Peyrin-Biroulet L, et al. Among authors: arkkila p. BMC Gastroenterol. 2024 Mar 27;24(1):121. doi: 10.1186/s12876-024-03163-5. BMC Gastroenterol. 2024. PMID: 38539103 Free PMC article.
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
Peyrin-Biroulet L, Bossuyt P, Bettenworth D, Loftus EV Jr, Anjie SI, D'Haens G, Saruta M, Arkkila P, Park H, Choi D, Kim DH, Reinisch W. Peyrin-Biroulet L, et al. Among authors: arkkila p. Dig Dis Sci. 2024 May;69(5):1808-1825. doi: 10.1007/s10620-023-08252-1. Epub 2024 Mar 18. Dig Dis Sci. 2024. PMID: 38499736 Free PMC article.
119 results